|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| C12N 15/62 | |||
| A61P 7/06 |
| (11) | Number of the document | 2468291 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11195140.6 |
| Date of filing the European patent application | 2007-12-18 | |
| (97) | Date of publication of the European application | 2012-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 87568206 P | 2006-12-18 | US |
| (72) |
Sherman, Matthew L., US
|
| (73) |
Acceleron Pharma, Inc.,
149 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |